Mga Batayang Estadistika
| CIK | 830052 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to RBC Life Sciences, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| February 12, 2016 |
S-8 POS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 RBC LIFE SCIENCES, INC. (Exact name of registrant as specified in its charter) Nevada 2301 Crown Court Irving, Texas 75038 91-2015186 (State or other jurisdiction of incorporation or organization) (Address, including zip |
|
| February 12, 2016 |
15-12G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 000-50417 RBC Life Sciences, Inc. (Exact Name of Registrant as Specif |
|
| February 9, 2016 |
RBCL / RBC Life Sciences, Inc. / ABRAHAMSON PETER JOHN - AMENDMENT NO. 2 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* RBC Life Sciences, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 74926T201 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of the Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| December 21, 2015 |
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 15, 2015 RBC Life Sciences, Inc. |
|
| November 16, 2015 |
RBC Life Sciences 10-Q (Quarterly Report) 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 000-50417 RBC Life Sc |
|
| July 21, 2015 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 15, 2015 RBC Life Sciences, Inc. |
|
| July 21, 2015 |
Exhibit 10.1 Sperry Van Ness Dunn Commercial N ORTH T EXAS C OMMERCIAL A SSOCIATION OF R EALTORS ? COMMERCIAL LEASE AGREEMENT between BCKK Investment Group, Inc. (Landlord) and American Christmas Light & Supply, Inc. (Tenant) TABLE OF CONTENTS Article 1. Defined Terms 2. Lease and Term 3. Rent and Security Deposit 4. Taxes 5. Insurance and Indemnity 6. Use of Premises 7. Property Condition, Mainte |
|
| July 21, 2015 |
Exhibit 10.2 T EXAS A SSOCIATION OF R EALTORS? COMMERCIAL SUBLEASE USE OF THIS FORM BY PERSONS WHO ARE NOT MEMBERS OF THE TEXAS ASSOCIATION OF REALTORS? IS NOT AUTHORIZED. ?Texas Association of REALTORS?, Inc. 2014 1. PARTIES: The parties to this sublease are: Sublessor: American Christmas Light & Supply, Inc. 704 E. 44th Street Lubbock, TX 79404 ; and Sublessee: Royal Bodycare Inc. 2301 Crown Ct. |
|
| June 30, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 24, 2015 RBC Life Sciences, Inc. |
|
| June 30, 2015 |
Exhibit 99.1 Exhibit 99.1 Mr. Steve Brown via email and US Mail Chief Executive officer RBC Life Sciences 2301 Crown Plaza Irving Texas 75038 Dear Steve I am in receipt of the current correspondence from Mr. Howard to the Board of Directors concerning his nomination of Mr. Chuck Boyce to the board and his intent to vote his family?s shares for Mr. Boyce. I find this news disturbing since it is in |
|
| June 4, 2015 |
EX-10.1 2 exhibit101.htm EXHIBIT 10.1 Sperry Van Ness Dunn Commercial NORTH TEXAS COMMERCIAL ASSOCIATION OF REALTORS® COMMERCIAL CONTRACT OF SALE [Check all boxes applicable to this Contract - Boxes not checked do not apply to this Contract] In consideration of the agreements contained in this Commercial Contract of Sale (the "Contract"), Seller shall sell and convey to Purchaser, and Purchaser sh |
|
| June 4, 2015 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits RBC 8K 20150528 Sale of Building UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2015 RBC Life Sciences, Inc. |
|
| April 28, 2015 |
RBC Def 14A 2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a |
|
| February 6, 2015 |
RBCL / RBC Life Sciences, Inc. / ABRAHAMSON PETER JOHN - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1)* RBC Life Sciences, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 74926T201 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| January 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 1, 2015 RBC Life Sciences, Inc. |
|
| October 1, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 26, 2014 RBC Life Sciences, Inc. |
|
| September 19, 2014 |
RBCL / RBC Life Sciences, Inc. / ABRAHAMSON PETER JOHN - SC 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. )* RBC Life Sciences, Inc. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 74926T201 (CUSIP Number) September 15, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this |
|
| August 28, 2014 |
EX-10.1 2 rbc8k201408x22ex101.htm EXHIBIT 10.1 EXHIBIT 10.1 EXCLUSIVE AGREEMENT This agreement (the “Agreement”) is made as of the 1st day of August, 2014, by and between RBC Life Sciences, Inc., a Nevada corporation with offices at 2301 Crown Court, Irving, Texas, 75038, USA, (“RBC” or “Supplier”), and Coral Club International Inc., an Ontario corporation, with offices at 255 Duncan Mill Road, Su |
|
| August 28, 2014 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits 8-K 1 rbc8k201408x22cciagreement.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 22, 2014 RBC Life Sciences, Inc. (Exact name of registrant as specified in its charter) NEVADA (State or other jurisdiction of incorporat |
|
| August 14, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 14, 2014 RBC Life Sciences, Inc. |
|
| August 14, 2014 |
RBC Life Sciences® RBC Life Sciences Reports Second Quarter Results EXHIBIT 99.1 RBC Life Sciences® Press Release For Further Information: For Immediate Release Steven E. Brown, President, CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Reports Second Quarter Results Irving, Texas, August 14, 2014 - RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management products, today re |
|
| June 20, 2014 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2014 RBC Life Sciences, Inc. |
|
| June 12, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 12, 2014 RBC Life Sciences, Inc. |
|
| June 12, 2014 |
EXHIBIT 99.1 RBC Life Sciences® Press Release For Further Information: For Immediate Release Steven E. Brown, President Tel: 972-893-4000 [email protected] Chairman and Chief Executive Officer of RBC Life Sciences Addresses Company Performance Irving, Texas, June 12, 2014 - RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pa |
|
| June 4, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2014 RBC Life Sciences, Inc. |
|
| May 14, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2014 RBC Life Sciences, Inc. |
|
| May 14, 2014 |
RBC Life Sciences® RBC Life Sciences Reports First Quarter Results EXHIBIT 99.1 RBC Life Sciences® Press Release For Further Information: For Immediate Release Richard S. Jablonski, VP - Finance and CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Reports First Quarter Results Irving, Texas, May 14, 2014 - RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management products |
|
| April 29, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| April 3, 2014 |
Termination of a Material Definitive Agreement - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 31, 2014 RBC Life Sciences, Inc. |
|
| March 27, 2014 |
RBC Life Sciences 10-K (Annual Report) RBCL 10-K 2013-12-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| March 27, 2014 |
EXHIBIT 99.1 RBC Life Sciences® Press Release For Further Information: For Immediate Release Richard S. Jablonski, VP-Finance and CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Reports 2013 Results Irving, Texas, March 27, 2014 - RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management products, today r |
|
| March 27, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 27, 2014 RBC LIFE SCIENCES, INC. |
|
| January 9, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 8, 2014 RBC Life Sciences, Inc. |
|
| October 23, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2013 RBC Life Sciences, Inc. |
|
| August 28, 2013 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 28, 2013 RBC Life Sciences, Inc. |
|
| August 28, 2013 |
RBC Life Sciences® RBC Life Sciences Announces Share Repurchase Program EX-99.1 2 pressrelease201308x27stoc.htm EXHIBIT RBC Life Sciences® Press Release For Further Information: For Immediate Release Richard S. Jablonski, VP - Finance and CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Announces Share Repurchase Program Irving, Texas, August 28, 2013 - RBC Life Sciences, Inc. (OTCQB: RBCLD), a provider of proprietary nutritional supplements, |
|
| August 9, 2013 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2013 RBC Life Sciences, Inc. |
|
| August 9, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2013 RBC Life Sciences, Inc. |
|
| August 9, 2013 |
RBC Life Sciences® RBC Life Sciences Announces Stock Splits RBC Life Sciences® Press Release For Further Information: For Immediate Release Richard S. |
|
| August 7, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2013 RBC Life Sciences, Inc. |
|
| August 7, 2013 |
RBC Life Sciences® RBC Life Sciences Reports Second Quarter Results EXHIBIT 99.1 RBC Life Sciences® Press Release For Further Information: For Immediate Release Richard S. Jablonski, VP - Finance and CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Reports Second Quarter Results Irving, Texas, August 7, 2013 - RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management produ |
|
| July 30, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 30, 2013 RBC Life Sciences, Inc. |
|
| June 19, 2013 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 19, 2013 RBC Life Sciences, Inc. |
|
| May 15, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 15, 2013 RBC LIFE SCIENCES, INC. |
|
| May 15, 2013 |
EXHIBIT 99.1 RBC Life Sciences® Press Release For Further Information: For Immediate Release Richard S. Jablonski, VP-Finance and CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Reports First Quarter 2013 Results Irving, Texas, May 15, 2013 - RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management produ |
|
| April 29, 2013 |
DEF 14A 1 rbcdef14a2013.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as pe |
|
| April 19, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| March 28, 2013 |
EXHIBIT 99.1 RBC Life Sciences® Press Release For Further Information: For Immediate Release Richard S. Jablonski, VP-Finance and CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Reports 2012 Results Irving, Texas, March 28, 2013 - RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management products, today r |
|
| March 28, 2013 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 28, 2013 RBC Life Sciences, Inc. |
|
| March 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 5, 2013 RBC Life Sciences, Inc. |
|
| November 8, 2012 |
RBC Life Sciences Reports Third Quarter 2012 Results EXHIBIT 99.1 Press Release For Further Information: For Immediate Release Richard S. Jablonski, VP, CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Reports Third Quarter 2012 Results Irving, Texas, November 8, 2012 - RBC Life Sciences, Inc. (OTCQB: RBCL) (the “Company), a provider of proprietary nutritional supplements, and wound care and pain management products, today |
|
| November 8, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 8, 2012 RBC Life Sciences, Inc. |
|
| August 23, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 20, 2012 RBC Life Sciences, Inc. |
|
| August 9, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2012 RBC Life Sciences, Inc. |
|
| August 9, 2012 |
RBC Life Sciences® RBC Life Sciences Reports Second Quarter 2012 Results EXHIBIT 99.1 RBC Life Sciences® Press Release For Further Information: For Immediate Release Richard S. Jablonski, VP, CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Reports Second Quarter 2012 Results Irving, Texas, August 9, 2012 - RBC Life Sciences, Inc. (OTCQB: RBCL) (the “Company), a provider of proprietary nutritional supplements, and wound care and pain managemen |
|
| August 7, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2012 RBC Life Sciences, Inc. |
|
| August 7, 2012 |
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into this 6th day of August, 2012 by and between RBC Life Sciences, Inc. |
|
| August 7, 2012 |
EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made and entered into this 6th day of August, 2012 by and between RBC Life Sciences, Inc. |
|
| July 27, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2012 RBC Life Sciences, Inc. |
|
| June 21, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 18, 2012 RBC Life Sciences, Inc. |
|
| June 12, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 7, 2012 RBC Life Sciences, Inc. |
|
| May 9, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2012 RBC Life Sciences, Inc. |
|
| May 9, 2012 |
EXHIBIT 99.1 RBC Life Sciences® Press Release For Further Information: For Immediate Release Steven E. Brown, Executive VP, CFO Tel: 972-893-4000 [email protected] RBC Life Sciences Reports First Quarter 2012 Results Irving, Texas, May 7, 2012 - RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care and pain management products, today |
|
| April 26, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| March 20, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 19, 2012 RBC Life Sciences, Inc. |
|
| March 20, 2012 |
EX-99.1 2 rbc8k111231ex991.htm NEWS RELEASE EXHIBIT 99.1 RBC Life Sciences® Press Release Steven E. Brown, Executive VP, CFO For Further Information: For Immediate Release Tel: 972-893-4000 [email protected] RBC Life Sciences Reports 2011 Results Irving, Texas, March 19, 2012 - RBC Life Sciences, Inc. (OTCQB: RBCL), a provider of proprietary nutritional supplements, and wound care an |
|
| February 16, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2012 RBC Life Sciences, Inc. |
